History
  • No items yet
midpage
Secrest v. Merck, Sharp & Dohme Corp.
2013 U.S. App. LEXIS 2125
| 2d Cir. | 2013
Read the full case

Background

  • Secrest appeals district court summary judgment for Merck on failure-to-warn regarding Fosamax and ONJ.
  • Treating physician Dr. Epstein provided conflicting deposition testimony in 2008 and 2011 after Merck’s motion.
  • Florida law requires warning to be addressed to physicians, with causation showing physician would stop drug if warned sufficiently.
  • Merck issued a 2005 warning; Secrest used Epstein’s later testimony to oppose summary judgment.
  • District Court deemed Epstein’s February 2011 testimony to be a sham or manufactured contradiction.
  • Court held no genuine dispute of material fact remained and affirmed judgment for Merck.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the district court erred in discarding Epstein's later testimony as a sham. Secrest argues contradictions are genuine and create fact disputes. Merck argues later testimony is sham since it contradicts prior sworn statements and lacks personal knowledge. No genuine dispute; court properly discarded sham testimony.
Whether Florida causation requires physician would stop Fosamax given a different warning. Secrest must show physician would have ceased treatment with adequate warning. Merck contends different warning would have changed physician action; causation exists if warning would have changed care. Causation is not established without physician's independent knowledge; no fact dispute.
Whether timing of the new expert testimony post-motion affects the ability to defeat summary judgment. Late-stage testimony can create a genuine issue of material fact. Post-motion testimony crafted to defeat summary judgment is suspect and permissible only if credible. Timing supports finding no genuine dispute; new testimony lacks credibility.

Key Cases Cited

  • Perma Research & Dev. Co. v. Singer Co., 410 F.2d 572 (2d Cir. 1969) (sham affidavit/contradictory testimony may defeat summary judgment)
  • AEP Energy Servs. Gas Holding Co. v. Bank of Am., N.A., 626 F.3d 699 (2d Cir. 2010) (timing and contradictions in expert testimony to defeat summary judgment)
  • Jeffreys v. City of New York, 426 F.3d 549 (2d Cir. 2005) (plausible explanations for inconsistencies; credibility issues for jury)
  • Rojas v. Roman Catholic Diocese of Rochester, 660 F.3d 98 (2d Cir. 2011) (inescapable contradictions support not considering inconsistent testimony)
  • Cutter Laboratories v. Cutter, 53 F.3d 1187 (2d Cir. 1995) (causation under Florida law; physician would stop if warning adequate)
  • Upjohn Co. v. MacMurdo, 562 So.2d 680 (Fla. 1990) (duty to warn directed to physician)
Read the full case

Case Details

Case Name: Secrest v. Merck, Sharp & Dohme Corp.
Court Name: Court of Appeals for the Second Circuit
Date Published: Jan 30, 2013
Citation: 2013 U.S. App. LEXIS 2125
Docket Number: Docket 11-4358-cv
Court Abbreviation: 2d Cir.